Burkitt’s lymphoma is one of the most aggressive tumors affecting humans. Multiple alterations in genes that regulate cell proliferation rate explain its aggressive behavior. A new study reveals new molecular insights into the understanding and treatment of Burkitt`s lymphoma. The new finding concentrates on a genetic locus — a piece of DNA with one or ...
Scientists at Duke Cancer Institute have discovered that genetic mutations found in brain tumors can alter tumor metabolism. This work could help lead to new designs for anti-cancer drugs based on the unique properties of these tumors. “Malignant glioma appears to be at least two large subclasses of diseases – one that involves mutations in ...
Registered Nurses – work in a Pediatric Oncology Clinic in the Middle East! Our client is a prestigious multi-specialty hospital group in Saudi Arabia, and is equipped with the most technologically advanced state-of-the-art equipment & infrastructure of the highest international standards. The hospital has specialised centres for IVF and Maternity, and has truly world-class tertiary ...
US Oncology, Inc., the nation’s leading integrated oncology company, announced that it has enrolled the 1,000th patient in a Phase I clinical trial through its US Oncology Research Network. Phase I clinical trials present special challenges, including increased safety concerns, higher variability of patient disease, more complex trial designs, and some first-in-human trials, making Phase ...
Researchers have dramatically advanced medicine’s understanding of how cancer migrates, showing that cancer cells are accompanied by growth-enabling stromal cells when they travel in the bloodstream to new sites in the body. The discovery by UNSW medical scientists challenges the prevailing belief that metastasis is the sole preserve of cancer cells. The finding has implications ...